Literature DB >> 10550082

Vertical transmission rates for HIV in the British Isles: estimates based on surveillance data.

T Duong1, A E Ades, D M Gibb, P A Tookey, J Masters.   

Abstract

OBJECTIVE: To estimate and interpret time trends in vertical transmission rates for HIV using data from national obstetric and paediatric surveillance registers.
DESIGN: Prospective study of HIV infected women reported through obstetric surveillance. HIV infection status of the child and onset of AIDS were reported through paediatric surveillance. Rates of vertical transmission and progression to AIDS rate were estimated by methods that take account of incomplete follow up of children with indeterminate infection status and delay in AIDS reporting.
SETTING: British Isles.
SUBJECTS: Pregnant women infected with HIV whose infection was diagnosed before delivery, and their babies. MAIN OUTCOME MEASURES: Mother to child transmission of infection and progression to AIDS in children.
RESULTS: By January 1999, 800 children born to diagnosed HIV infected women who had not breast fed had been reported. Vertical transmission rates rose to 19.6% (95% confidence interval 8. 0% to 32.5%) in 1993 before falling to 2.2% (0% to 7.8%) in 1998. Between 1995 and 1998 use of antiretroviral treatment increased significantly each year, reaching 97% of live births in 1998. The rate of elective caesarean section remained constant, at around 40%, up to 1997 but increased to 62% in 1998. Caesarean section and antiretroviral treatment together were estimated to reduce risk of transmission from 31.6% (13.6% to 52.2%) to 4.2% (0.8% to 8.5%). The proportion of infected children developing AIDS in the first 6 months fell from 17.7% (6.8% to 30.8%) before 1994 to 7.2% (0% to 15. 7%) after, coinciding with increased use of prophylaxis against Pneumocystis carinii pneumonia.
CONCLUSIONS: In the British Isles both HIV related morbidity and vertical transmission are being reduced through increased use of interventions.

Entities:  

Mesh:

Year:  1999        PMID: 10550082      PMCID: PMC28270          DOI: 10.1136/bmj.319.7219.1227

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  8 in total

1.  Prevention of vertical HIV transmission: additive protective effect of elective Cesarean section and zidovudine prophylaxis. Swiss Neonatal HIV Study Group.

Authors:  C Kind; C Rudin; C A Siegrist; C A Wyler; K Biedermann; U Lauper; O Irion; J Schüpbach; D Nadal
Journal:  AIDS       Date:  1998-01-22       Impact factor: 4.177

2.  The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies.

Authors:  W Andiman; Y Bryson; M de Martino; M Fowler; D Harris; C Hutto; B Korber; A Kovacs; S Landesman; M Lindsay; N Lapointe; L Mandelbrot; M-L Newell; H Peavy; J Read; C Rudin; A Semprini; R Simonds; R Tuomala
Journal:  N Engl J Med       Date:  1999-04-01       Impact factor: 91.245

3.  Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial.

Authors: 
Journal:  Lancet       Date:  1999-03-27       Impact factor: 79.321

4.  Epidemiology and detection of HIV-1 among pregnant women in the United Kingdom: results from national surveillance 1988-96.

Authors:  A Nicoll; C McGarrigle; A R Brady; A E Ades; P Tookey; T Duong; J Mortimer; S Cliffe; D Goldberg; D Tappin; C Hudson; C Peckham
Journal:  BMJ       Date:  1998-01-24

5.  Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects. Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study.

Authors:  P Lorenzi; V M Spicher; B Laubereau; B Hirschel; C Kind; C Rudin; O Irion; L Kaiser
Journal:  AIDS       Date:  1998-12-24       Impact factor: 4.177

6.  Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Authors:  E M Connor; R S Sperling; R Gelber; P Kiselev; G Scott; M J O'Sullivan; R VanDyke; M Bey; W Shearer; R L Jacobson
Journal:  N Engl J Med       Date:  1994-11-03       Impact factor: 91.245

7.  Perinatal HIV-1 transmission: interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort.

Authors:  L Mandelbrot; J Le Chenadec; A Berrebi; A Bongain; J L Bénifla; J F Delfraissy; S Blanche; M J Mayaux
Journal:  JAMA       Date:  1998-07-01       Impact factor: 56.272

8.  U.S. Public Health Service recommendations for human immunodeficiency virus counseling and voluntary testing for pregnant women.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1995-07-07
  8 in total
  22 in total

1.  General practitioners' attitudes and beliefs on antenatal testing for HIV: postal questionnaire survey.

Authors:  S Whittet; P Trail; A de Ruiter; D O'Sullivan; R Jones
Journal:  BMJ       Date:  2000-10-14

2.  Antenatal detection of HIV: national surveillance and unlinked anonymous survey.

Authors:  S Cliffe; P A Tookey; A Nicoll
Journal:  BMJ       Date:  2001-08-18

3.  Advances in the prevention and treatment of paediatric HIV infection in the United Kingdom.

Authors:  M Sharland; D M Gibb; G Tudor-Williams
Journal:  Arch Dis Child       Date:  2002-09       Impact factor: 3.791

Review 4.  Advances in the prevention and treatment of paediatric HIV infection in the United Kingdom.

Authors:  M Sharland; D M Gibb; G Tudor-Williams
Journal:  Sex Transm Infect       Date:  2003-02       Impact factor: 3.519

5.  Reducing vertical transmission of HIV in the UK.

Authors:  A Nicoll; C Peckham
Journal:  BMJ       Date:  1999-11-06

6.  Beyond counting cases: public health impacts of national Paediatric Surveillance Units.

Authors:  D Grenier; E J Elliott; Y Zurynski; R Rodrigues Pereira; M Preece; R Lynn; R von Kries; H Zimmermann; N P Dickson; D Virella
Journal:  Arch Dis Child       Date:  2006-12-11       Impact factor: 3.791

7.  Factors Associated with Maternal-Child Transmission of HIV-1 in Southeastern Brazil: A Retrospective Study.

Authors:  Thiago Nascimento do Prado; Deborah Bain Brickley; Nancy K Hills; Eliana Zandonade; Sandra Fagundes Moreira-Silva; Angélica Espinosa Miranda
Journal:  AIDS Behav       Date:  2018-07

8.  Comparison of auditory brainstem response in HIV-1 exposed and unexposed newborns and correlation with the maternal viral load and CD4+ cell counts.

Authors:  Ayotunde James Fasunla; Babatunde Oluwatosin Ogunbosi; Georgina Njideka Odaibo; Onyekwere George Benjamin Nwaorgu; Babafemi Taiwo; David Olufemi Olaleye; Kikelomo Osinusi; Robert Leo Murphy; Isaac Folorunso Adewole; Olusegun Olusina Akinyinka
Journal:  AIDS       Date:  2014-09-24       Impact factor: 4.177

9.  Five year follow up of vertically HIV infected children in a randomised double blind controlled trial of immediate versus deferred zidovudine: the PENTA 1 trial.

Authors: 
Journal:  Arch Dis Child       Date:  2001-03       Impact factor: 3.791

10.  Monitoring the effectiveness of HIV and STI prevention initiatives in England, Wales, and Northern Ireland: where are we now?

Authors:  A E Brown; S E Tomkins; L E Logan; D S Lamontagne; H L Munro; V D Hope; A Righarts; J E Blackham; B D Rice; T R Chadborn; P A Tookey; J V Parry; V Delpech; O N Gill; K A Fenton
Journal:  Sex Transm Infect       Date:  2006-02       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.